New injection shows promise for cholesterol control
NCT ID NCT07412080
First seen Feb 22, 2026 · Last updated May 25, 2026 · Updated 16 times
Summary
This early-stage study tested a single injection of a new drug called EDP167 in 40 healthy volunteers and people with mild dyslipidemia (abnormal cholesterol levels). The goal was to check if the injection is safe and how the body processes it. This is a first step to see if the drug can help manage cholesterol levels long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE AND FEMALE VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Guangdong Provincial People's Hospital
Guangzhou, China
-
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, China
Conditions
Explore the condition pages connected to this study.